Thoracoscopic Sympathectomy for Blushing

Odense University Hospital100 enrolled

Overview

To determine outcome and side effects following thoracoscopic sympathectomy in patients treated for disabling isolated facial blushing and investigate if there are any significant differences between two different routine procedures: T2 or T2-T3 sympathectomy.

To determine the outcome and side effects following thoracoscopic sympathectomy in patients treated for disabling isolated facial blushing. In addition, following randomization investigate if there are any significant differences between two different routine procedures: T2 or T2-T3 sympathectomy. Includes QoL before and 12 months after surgery

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

100

Conditions

Facial Blushing

Interventions

Level of sympathectomyPROCEDURE

T2 sympathectomy or T2-T3 sympathectomy

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Isolated disabling facial blushing * Over 18 years of age * Willing to be randomized Exclusion Criteria: * Primary hyperhidrosis in palms or axillae * Previous lung surgery * Bradycardia * Arrythmias * Pregnancy

Locations (2)

Dept Cardiothoracic Surgery, Skejby Sygehus, Aarhus University Hospital

Aarhus, Denmark

Dept Cardiothorcic Surgery, Odense University Hospital

Odense, Denmark

Outcomes

Primary Outcomes

Effect of operation. Side effects: compensatory and gustatory sweating.

Time frame: 12 months after surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.